A patient is described in whom malignant hypertension led to oliguric renal failure. A course of trimethoprim and sulphamethoxazole (co-trimoxazole) was prescribed for an intercurrent urinary tract infection and appeared to precipitate a megaloblastic anaemia which responded satisfactorily to folic acid.
Introduction
Sulphonamides interfere with the conversion of para-aminobenzoic acid to dihydrofolic acid. Trimethoprim interferes with the conversion of dihydrofolic acid to tetrahydrofolic acid by interfering with the enzyme dihydrofolic acid reductase. The bacterial enzyme is x 10,000 more sensitive than the mammalian enzyme to trimethoprim. Usually this selective toxicity enables one to eradicate bacterial infection without significantly interfering with the metabolism of the mammalian host. However, there are several reports demonstrating an effect of the trimethoprim-sulphonamide combination on human folic acid metabolism. Kahn, Fein & Brodsky (1968) administered trimethoprim to a group of patients with normal blood counts and blood urea. One patient's haemoglobin fell from 14-0 to 8-7 g/100 ml; another's platelet count fell from 200,000 to 60,000/mm3. They also observed a rise in the polymorphonuclear lobe count, a rise in FIGLU excretion, and giant metamyelocytes and transitional megaloblastic erythroid changes in the bone marrow.
They treated a second group of patients with trimethoprim and sulphamethoxazole (co-trimoxazole) and reported the following abnormalities: leucopenia, granulocytopenia, thrombocytopenia, and an increase in FIGLU excretion. Bone marrows were not examined in this group. Allison et al. (1969) and Hulme & Reeves (1971) also reported similar abnormalities.
The current case report is of a patient who was given co-trimoxazole whilst oliguric and who developed severe megaloblastic anaemia, thrombocytopenia and mild leucopenia. The falling platelet count was attributed to haemolytic uraemic syndrome, but the fall in the reticulocyte count was not explained. At the same time it was noticed that the haemoglobin was falling steadily despite no overt source of blood loss and reasonable control of her uraemia. A blood film at this time showed some hypersegmented polymorphs, and occasional macrocytes. The platelet count reached 40,000 and a sternal marrow was performed which demonstrated megaloblastic changes in the erythroid series and occasional giant metamyelocytes and raised iron stores. She was treated empirically with 1000 ,ug of vitamin B12 daily, 15 mg of folic acid parenterally daily from 10 September for I week and the Septrin was stopped on 13 September. On 16 September her haemoglobin was rising and she had a brisk reticulocytosis and the platelet count had reached 200,000. The serum B12 + folate analysis was then returned, the B12 was 295 pg/ml and the serum folate level was 0-1 ng/ml and further B12 therapy was stopped (Fig. 1) .
She was established on intermittent haemodialysis on 2 October, with the blood urea ranging from 60 to 80 mg/100 ml and by 12 October the haemoglobin was 6-9 gm/100 ml, white cells 9000/mm3, and reticulocytes 64. A repeat sternal marrow was performed (15 October) and showed normoblastic erythropoiesis with strikingly deficient iron stores, a finding in marked contrast to the previous marrow. There was defective haemoglobinization and she is currently being treated with a course of intravenous iron. On 23 November her haemoglobin was 11 6 g/100 ml.
Discussion
We think that the unusual degree of interference with human folic acid metabolism found in this case was due to a combination of several factors. As the estimated folic acid requirement is 50-100
[ig daily (De Gruchy, 1970) it is obvious that the patient's dietary folic acid intake was at a critical level. It is interesting to recall that Kahn (1968) showed in his study that haematological interference by co-trimoxazole could be prevented by 400 ,ig folic acid daily. Sharpstone (1969) showed that defective excretion of co-trimoxazole did not occur until creatinine clearance fell below 3-5 ml/min. Therefore, our patient whose clearance of creatinine was approximately 1 ml/min would have developed drug retention at a time when her dietary intake was below the level of 400 ,zg folic acid-the level shown by Kahn to be necessary to counteract co-trimoxazole antagonism of folic acid. In addition to these factors, however, it may be expected that her folic acid consumption was much higher than normal as she had evidence of a significant haemolytic anaemia. It is well known that a haemolytic anaemia may cause megaloblastic anaemia due to depletion of body folic acid storesChanarin, Dacie & Mollin (1959) . On the other hand, Clarkson et al. (1970) did not comment on megaloblastic anaemia in his cases with the haemolytic uraemic syndrome.
Finally, during the later stages of her illness, she had several peritoneal dialyses. Sevitt & Hoffbrand (1969) GROSS foetal malformations of the acardiac variety are exceedingly rare. As the name implies, the chief abnormality common to all varieties of the monster is the lack of a functioning heart.
The monster is always one of a pair of uniovular twins, but has been reported in a triplet pregnancy (Ross, 1951) . The other foetus, whose heart provides the circulatory force for both twins, is usually normal.
The incidence of acardiac monsters is difficult to ascertain. However, Kappelman (1944) has estimated that they occur approximately once in 34,600 births.
